EVS reports 2024 results EVS Achieves Record Revenue for Fourth Consecutive Year in 2024, Celebrating 30 Years of Success Liège, Belgium | February 18, 2025 2024 marks a significant milestone ...
Additional analysis of data from the NAVIGATE trial showed statistically significant 68.1% (p=0.02) reduction in the incidence of new varices ...
Galectin Therapeutics (GALT) announced additional results showing a statistically significant reduction in new varices in per-protocol patients ...
My previous article on the Commanders’ running game revealed that the ability of the running backs to get off the line ...
Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation"), one of Canada's largest logistics providers today reported its ...